Ganie, Z. A., Stratman, G. and Jhala, A. J. 2015. Response of selected glyphosate-resistant broadleaved weeds to premix of fluthiacet-methyl and mesotrione (Solstice™) applied at two growth stages. Can. J. Plant Sci. 95: 861-869. A premix of fluthiacet-methyl and mesotrione (1:17.5 ratio) has recently been registered for post-emergence (POST) broadleaf weed control in corn. The objective of this study was to determine the response of glyphosate-resistant common waterhemp, giant ragweed, and kochia to a premix of fluthiacet-methyl and mesotrione when applied to 10- and 20-cm-tall plants. Greenhouse dose response studies were conducted and log-logistic models were used to determine how the response varies between the weed species at two growth stages under various rates ranging from 21.8 to 218.5 g a.i. ha-1 (0.25× to 2.5×). The effective rate required to achieve >90% control and shoot biomass reduction varied depending on the weed species and growth stage. The rates required for 90% control (ED90) of 10-cm-tall glyphosate-resistant common waterhemp, giant ragweed, and kochia were 78, 251, and 17 g a.i. ha-1, respectively, compared with 144, 489, and 79,349 g a.i. ha-1, respectively, for 20-cm-tall plants at 21 d after treatment (DAT). Based on visual control estimates at ED90 level, glyphosate-resistant common waterhemp was the most sensitive at both growth stages; kochia was sensitive at 10-cm height, while giant ragweed was the least sensitive at both growth stages. Irrespective of weed species or growth stage, the ED90 values calculated on the basis of shoot biomass reduction were mostly higher compared with visual control estimates. It is concluded that premix of fluthiacet-methyl plus mesotrione can be potentially used as a POST herbicide in corn for controlling glyphosate-resistant common waterhemp and kochia (≤ 10 cm tall) at the labeled rate (87 g a.i. ha-1).
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.